Latest: Watch here for details of new products and services.
- About Us
- Pharmalicensing - Open Innovation for the life sciences
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Due Diligence
- Comparison
- Due Diligence
- Overview
- Top Applications
- Online Panel Discussions
- Request Consultation
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire
- Jobs
- Forums
- Contact Pharmalicensing
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- Companies
- Browse
Companies
Medical School - Teaching Hospital - Research Institution More
Genecom is the commercialisation arm of the Moredun Institute and the Institute for Animal Health. These institutes have international reputations in the area of animal health. More
The IRC Network Biotechnology Thematic Group's goal is to contribute to the promotion of innovation in the European Biotechnology sector through technology transfer. More
QMUL aims to create social and economic benefits for society by developing a culture of innovation and enterprise that will facilitate the commercial exploitation of academic research and technology. More
The company positions itself as a distributor for API's and hospital specialty compounds: ATU's, generic portfolio for oncology, anti-emesis, pain management as well as intensive care . More
The Deutsche Krebsforschungszentrum (DKFZ) Heidelberg was founded as a non-profit organization and supraregional research center by the Land (state) Baden-Württemberg in 1964. More
Proteome Sciences is a global leader in applied proteomics applying high sensitivity proprietary technologies to detect differentially expressed proteins in diseases. More
Good Biotech Corporation (GBC) is a leading producer of industrial scale high-purity polyclonal IgY(-Fc) antibodies from duck egg yolk, offering a wide range of biotechnology applications. More
Your selection
Browse By
- Industry sector
- Animal health
- Biotech
- Diagnostic
- Drug delivery
- Medical device
- Pharmaceutical
- Therapeutic target
- Adoptive immunotherapy
- Amyloidosis
- Autoimmune disease (non-specific)
- Chronic fatigue syndrome
- Chronic granulomatous disease
- Chronic immunosuppression
- Gout
- Graft versus host disease
- HIV/AIDS
- Immune disorder (non-specific)
- Immune thrombocytopenic purpura
- Immunomodulation
- Immunostimulation
- Immunosuppression
- Lupus erythematosis
- Myalgic encephalomyelitis
- Myasthenia gravis
- Neoplastic disease
- Organ transplant rejection
- Rheumatoid arthritis
- Servere combined immunodeficency
- Sjogren's syndrome
- Systemic sclerosis
- Transplant rejection
- Xenotransplantation
- Geographic location
- Africa
- Asia
- Australia/New Zealand
- Central America
- Europe
- Near & Far East
- North America
- South America
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us